Brookdale Senior Living Inc. (BKD) AI Stock Analysis

Brookdale Senior Living Inc. operates senior living communities across the United States, offering residential options and care services for older adults. The company operates through three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). Its Independent Living segment features communities with independent and assisted living units for middle to upper income seniors. The Assisted Living and Memory Care segment provides freestanding communities offering housing, daily living assistance, and specialized dementia and Alzheimer's care. CCRCs offer a continuum of care including skilled nursing. As of December 31, 2021, the company owned 347 communities, leased 299, and managed 33.

Brookdale's annual revenue rose from $2.75B in FY2021 to $3.12B in FY2025, reflecting a 5-year revenue CAGR of 0.7%. Gross margin expanded from 17.8% in FY2021 to 27.1% in FY2024 before dropping to 20.6% in FY2025. Operating margin turned positive in FY2023 at 0.6% and stood at 0.5% in FY2025. However, net losses persisted throughout the period, totaling -$99.3M in FY2021, -$238.4M in FY2022, -$189.0M in FY2023, -$201.9M in FY2024, and -$262.7M in FY2025. For the trailing twelve months ended June 30, 2026, revenue was $2.93B with an operating margin of 6.8% and a net margin of -4.7%, as latest quarter revenue declined 8.9% year-over-year.

As of June 30, 2026, Brookdale held $390.3M in cash and short-term investments against total debt of $1.29B, resulting in net debt of $898.9M. Shareholders' equity was -$29.0M on total assets of $5.90B, and its current ratio was 1.14. Operating cash flow improved over recent years to $218.0M in FY2025, enabling the company to generate $16.5M in free cash flow after capital expenditures of $201.5M. The company spent $6.5M on share buybacks in FY2025, while its share count increased 31.6% over five years.

At $10.09 per share, Brookdale has a market capitalization of $2.41B and an enterprise value of $7.77B. It trades at a forward P/E of 45.7x, above the 17.3x median of its US-listed Healthcare peers. Its EV/EBITDA of 18.1x is also higher than the peer median of 12.0x, though its price-to-sales of 0.8x is lower than the peer median of 4.1x. Over the past year, BKD returned 16.5%, close to the S&P 500 (SPY) return of 16.8%, but its 5-year gain of 52.9% trailed the S&P 500 return of 83.0%.

Brookdale has 4 Strong Buy and 2 Buy recommendations, with no Hold or Sell ratings. The mean price target is $19.08, representing an 89.1% premium over the last close of $10.09. For the fiscal year ending December 31, 2026, analysts estimate an EPS of -$0.62 on revenue of $2.93B. For FY2027, the consensus EPS estimate is $0.12 on $3.00B in revenue. The company beat EPS expectations in 2 of the last 4 quarters, and its next earnings date is November 5, 2026.

This page is an AI-written research summary of Brookdale Senior Living Inc. (BKD). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: BKD income statement, BKD balance sheet, BKD key metrics, BKD analyst forecast, BKD chart. See the BKD stock overview for the latest quote and news.